Toggle navigation
Campus Access
About MPG.eBooks
Skip to content
Search Tips
Home
>
Search: "Insurance, Health, Reimbursement"
Language
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文（繁體）
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
All Fields
Title
Person
Topic
ISBN/ISSN
Year
Collection
Advanced
Showing
41
-
60
of
136
Search:
'"Insurance, Health, Reimbursement"'
,
query time: 0.16s
Book List
0
Sort:
Relevance
Year Descending
Year Ascending
Author
Title
Read Now
41
CADTH Canadian Drug Expert Committee recommendation: Brexpiprazole (Rexulti - Lundbeck Canada Inc and Otsuka Canada Pharmaceutical Inc.) : indication : treatment of schizophrenia i...
Published 2017
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...
Insurance
,
Health
,
Reimbursement
...
”
Read Now
42
Pharmacoeconomic review report: Brexpiprazole (Rexulti) : (Lundbeck Canada Inc. and Otsuka Canada Pharmaceutical Inc.) : indication: treatment of schizophrenia in adults
Published 2017
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...
Insurance
,
Health
,
Reimbursement
/ economics...
”
Read Now
43
CADTH Canadian drug expert committee recommendation: Doravirine/Lamivudine/Tenofovir disoproxil fumarate (Delstrigo -- Merck Canada Inc.) : indication: as a complete regimen for th...
Published 2019
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...
Insurance
,
Health
,
Reimbursement
...
”
Read Now
44
CADTH Canadian Drug Expert Committee final recommendation: Omalizumab -- resubmission (Xolair -- Novartis Pharmaceuticals Canada Inc.) : indication: asthma
Published 2016
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...
Insurance
,
Health
,
Reimbursement
/ economics...
”
Read Now
45
CADTH Canadian drug expert committee recommendation: Patisiran (Onpattro -- Alnylam Netherlands BV) : indication : for the treatment of polyneuropathy in adult patients with heredi...
Published 2019
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...
Insurance
,
Health
,
Reimbursement
...
”
Read Now
46
CADTH Canadian Drug Expert Committee recommendation: Ozenoxacin 1% cream (Ozanex -- Ferrer Internacional, S.A.) : indication: the topical treatment of impetigo in patients aged two...
Published 2018
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...
Insurance
,
Health
,
Reimbursement
...
”
Read Now
47
CADTH Canadian Drug Expert Committee recommendation: Cladribine (Mavenclad -- EMD Serono) : indication: relapsing-remitting multiple sclerosis
Published 2018
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...
Insurance
,
Health
,
Reimbursement
...
”
Read Now
48
CADTH Canadian Drug Expert Committee recommendation: Levodopa/carbidopa intestinal gel (Duodopa -- Abbvie Corporation) : indication : Parkinson's disease
Published 2018
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...
Insurance
,
Health
,
Reimbursement
...
”
Read Now
49
CADTH Canadian Drug Expert Committee recommendation: Tocilizumab (Actemra - Hoffmann-La Roche Limited) : indication : giant cell arteritis
Published 2018
CADTH
Subjects:
“
...
Insurance
,
Health
,
Reimbursement
...
”
Read Now
50
CADTH Canadian Drug Expert Committee recommendation: Ozenoxacin 1% cream (Ozanex -- Ferrer Internacional, S.A.) : indication: the topical treatment of impetigo in patients aged two...
Published 2018
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...
Insurance
,
Health
,
Reimbursement
...
”
Read Now
51
CADTH Canadian Drug Expert Committee recommendation: Levodopa/carbidopa intestinal gel (Duodopa -- Abbvie Corporation) : indication : Parkinson's disease
Published 2018
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...
Insurance
,
Health
,
Reimbursement
...
”
Read Now
52
CADTH Canadian Drug Expert Committee recommendation: Lumacaftor/Ivacaftor (Orkambi -- Vertex Pharmaceuticals (Canada) Incorporated) : indication : cystic fibrosis, F508del-cystic f...
Published 2018
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...
Insurance
,
Health
,
Reimbursement
...
”
Read Now
53
CADTH Canadian Drug Expert Committee recommendation: AbobotulinumtoxinA (Dysport therapeutic--Ipsen Biopharmaceuticals Canada, Inc.) : indication : for the symptomatic treatment of...
Published 2018
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...
Insurance
,
Health
,
Reimbursement
...
”
Read Now
54
CADTH Canadian Drug Expert Committee recommendation: Lumacaftor/Ivacaftor (Orkambi -- Vertex Pharmaceuticals (Canada) Incorporated) : indication : cystic fibrosis, F508del-cystic f...
Published 2018
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...
Insurance
,
Health
,
Reimbursement
...
”
Read Now
55
CADTH Canadian Drug Expert Committee recommendation: AbobotulinumtoxinA (Dysport therapeutic--Ipsen Biopharmaceuticals Canada, Inc.) : indication : for the symptomatic treatment of...
Published 2018
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...
Insurance
,
Health
,
Reimbursement
...
”
Read Now
56
CADTH Canadian Drug Expert Committee recommendation: Ivabradine hydrochloride (Lancora -- Servier Canada Inc.) : indication: heart failure, NYHA class II to III.
Published 2017
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...
Insurance
,
Health
,
Reimbursement
/ economics...
”
Read Now
57
CADTH Canadian Drug Expert Committee final recommendation: Sapropterin -- resubmission (Kuvan -- BioMarin Pharmaceuticals Canada Inc.) : indication: to reduce blood phenylalanine l...
Published 2016
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...
Insurance
,
Health
,
Reimbursement
/ economics...
”
Read Now
58
CADTH Canadian Drug Expert Committee recommendation: Tocilizumab (Actemra - Hoffmann-La Roche Limited) : indication : giant cell arteritis
Published 2018
CADTH
Subjects:
“
...
Insurance
,
Health
,
Reimbursement
...
”
Read Now
59
CADTH Canadian Drug Expert Committee recommendation: Insulin glargine and lixisenatide (Soliqua -- Sanofi-Aventis Canada Inc.) : indication : adjunct to diet and exercise to improv...
Published 2019
CADTH
Subjects:
“
...
Insurance
,
Health
,
Reimbursement
...
”
Read Now
60
CADTH Canadian Drug Expert Committee recommendation: Isavuconazole (Cresemba -- Avir Pharma Inc.) : indication : for use in adults for the treatment of invasive aspergillosis, inva...
Published 2019
CADTH
Subjects:
“
...
Insurance
,
Health
,
Reimbursement
...
”
1
2
3
4
5
6
7
Back
Narrow Search
Year of Publication
From:
To:
Classification
610 - Medicine & health
136
330 - Economics
94
140 - Specific philosophical schools
14
700 - The arts; fine & decorative arts
12
519 - Probabilities & applied mathematics
1
Language
English
136
Collection
National Center for Biotechnology Information
135
O'Reilly
1
Author
CADTH Canadian Drug Expert Committee
125
Canadian Agency for Drugs and Technologies in Health
102
Abernethy, Amy Pickar
1
Dickstein, Craig
1
Duke University Evidence-based Practice Center
1
European Observatory on Health Systems and Policies
1
more ...
Gehring, Renu
1
Panteli, Dimitra
1
Paris, Valérie
1
Richardson, Erica
1
Technology Assessment Program (Agency for Healthcare Research and Quality)
1
United States Agency for Healthcare Research and Quality
1
Vogler, Sabine
1
World Health Organization Regional Office for Europe
1
see all ...
less ...
Search Tools
Get RSS Feed
Share Search
https://ebooks.mpdl.mpg.de/ebooks/Search/Results?page=3&lookfor=%22Insurance%2C+Health%2C+Reimbursement%22&type=Subject
Send by Email
×
Loading...